Raven LM, Stoita A, Feller RB, Brown C, Greenfield JR
Medicaid's categorical exclusion of weight loss GLP-1s leaves no coverage pathway, but some patients reduce costs by extending vials through lower-frequency dosing or splitting the therapeutic dose across a longer titration schedule
Over time, factors will conspire to make it more widely covered and cheaper
Dont store MT2 in the door, where temps fluctuate 2
There is compelling evidence, including low plasma levels of GSH [12, 13], and effective antioxidant therapies (both with GSH [14] and its precursor, N-acetylcysteine [14, 15]), of REDOX imbalance contributing to the pathophysiology of several brain conditions such as obsessive-compulsive disorder, schizophrenia, bipolar disorder, autism, trichotillomania, and neurodegenerative disorders (see refs